{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:08:14Z","timestamp":1791331694824,"version":"4.3.1"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>MicroRNAs are small non-coding RNAs that are detectable in plasma and serum. Circulating levels of microRNAs have been measured in various studies related to cardiovascular disease. Heparin is a potential confounder of microRNA measurements due to its known interference with polymerase chain reactions. In this study, platelet-poor plasma was obtained from patients undergoing cardiac catheterisation for diagnostic coronary angiography, or for percutaneous coronary intervention, both before and after heparin administration. Heparin had pronounced effects on the assessment of the exogenous C. elegans spike-in control (decrease by approx. 3 cycles), which disappeared 6 hours after the heparin bolus. Measurements of endogenous microRNAs were less sensitive to heparin medication. Normalisation of individual microRNAs with the average cycle threshold value of all microRNAs provided a suitable alternative to normalisation with exogenous C. elegans spike-in control in this setting. Thus, both the timing of blood sampling relative to heparin dosing and the normalisation procedure are critical for reliable microRNA measurements in patients receiving intravenous heparin. This has to be taken into account when designing studies to investigate the relation of circulating microRNAs to acute cardiovascular events or coronary intervention.<\/jats:p>","DOI":"10.1160\/th13-05-0368","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T10:04:40Z","timestamp":1372327480000},"page":"609-615","source":"Crossref","is-referenced-by-count":83,"title":["Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease"],"prefix":"10.1160","volume":"110","author":[{"given":"Dorothee","family":"Kaudewitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regent","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Willeit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"McGregor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Markus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kiechl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zampetaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Channon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCRESAHA.107.163147","article-title":"Emerging role of microRNAs in cardiovascular biology","volume":"101","author":"MV Latronico","year":"2007","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","article-title":"Toward microRNA-based therapeutics for heart disease: the sense in antisense","volume":"103","author":"E van Rooij","year":"2008","journal-title":"Circ Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.110.218123","article-title":"The many faces of endothelial microparticles","volume":"31","author":"F Dignat-George","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"A Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"KC Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"JD Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/ATVBAHA.112.300141","article-title":"MicroRNAs within the continuum of postgenomics biomarker discovery","volume":"33","author":"M Mayr","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating microRNAs and risk of myocardial infarction","volume":"60","author":"A Zampetaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCRESAHA.111.247445","article-title":"MicroRNAs in vascular and metabolic disease","volume":"110","author":"A Zampetaki","year":"2012","journal-title":"Circ Res"},{"key":"ref11","volume-title":"Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease","author":"HC de Boer","year":"2013"},{"key":"ref12","volume-title":"Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra","author":"E Cavarretta","year":"2013"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","article-title":"Circulating microRNAs as novel biomarkers for platelet activation","volume":"112","author":"P Willeit","year":"2013","journal-title":"Circ Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.113.300859","article-title":"Platelet microRNAs: Novy Mir* or mired in human complexity?","volume":"112","author":"AM Curtis","year":"2013","journal-title":"Circ Res"},{"key":"ref15","volume-title":"Artifactual elevation of plasma sCD40L by residual platelets in patients with coronary artery disease","author":"R Lee","year":"2013"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1160\/TH12-02-0097","article-title":"Analytical challenges and technical limitations in assessing circulating MiRNAs","volume":"108","author":"A Zampetaki","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2012.199505","volume-title":"Heparin selectively affects the quantification of microRNAs in human blood samples","author":"JN Boeckel","year":"2013"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.105.590083","article-title":"Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase","volume":"113","author":"S Baldus","year":"2006","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2012.06.105","article-title":"Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9","volume":"163","author":"R Lee","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cvr\/cvr266","article-title":"Profiling of circulating microRNAs: from single biomarkers to re-wired networks","volume":"93","author":"A Zampetaki","year":"2012","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin-protein interactions","volume":"41","author":"I Capila","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0","article-title":"Effects of heparin on polymerase chain reaction for blood white cells","volume":"13","author":"M Yokota","year":"1999","journal-title":"J Clin Lab Anal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(94)92622-0","article-title":"Effect of heparin on polymerase chain reaction","volume":"343","author":"J Satsangi","year":"1994","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1042\/bj1170623","article-title":"Micro-analysis of pure deoxyribonucleic acid-dependent ribonucleic acid polymerase from Escherichia coli. Action of heparin and rifampicin on structure and function","volume":"117","author":"V Neuhoff","year":"1970","journal-title":"Biochem J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/nar\/18.11.3255","article-title":"Heparin inhibits EcoRI endonuclease cleavage of DNA at certain EcoRI sites","volume":"18","author":"JZ Chen","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0003-9861(74)90050-2","article-title":"Inhibition and dissociation of mammalian polymeric DNA polymerase by heparin","volume":"164","author":"LH Lazarus","year":"1974","journal-title":"Arch Biochem Biophys"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"26616","DOI":"10.1074\/jbc.M111.224212","article-title":"Heparin impairs angiogenesis through inhibition of microRNA-10b","volume":"286","author":"X Shen","year":"2011","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1093\/nar\/19.21.6051","article-title":"Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood","volume":"19","author":"S Izraeli","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"ref29","first-page":"335","article-title":"Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin","volume":"146","author":"M Tsai","year":"1995","journal-title":"Am J Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2011.05.012","article-title":"An optimized sensitive method for quantitation of DNA\/RNA viruses in heparinized and cryopreserved plasma","volume":"176","author":"M Ding","year":"2011","journal-title":"J Virol Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.yjmcc.2011.07.011","article-title":"Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome","volume":"51","author":"C Widera","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/emmm.201201749","article-title":"Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs","volume":"04","author":"MI Oerlemans","year":"2012","journal-title":"EMBO Mol Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating MicroRNA-208b and MicroRNA-499 Reflect myocardial damage in cardiovascular disease","volume":"03","author":"MF Corsten","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-511X-11-55","article-title":"Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease","volume":"11","author":"W Gao","year":"2012","journal-title":"Lipids Health Dis"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-05-0368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:03:38Z","timestamp":1685534618000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-05-0368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":34,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2017,11,29]]},"published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-05-0368","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}